Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts

Platinum resistance is an unmet medical need in ovarian carcinoma. Molecular biomarkers to predict the response to platinum-based therapy could allow patient stratification and alternative therapeutic strategies early in clinical management. Sensitivity and resistance to platinum therapy are partial...

Descripción completa

Detalles Bibliográficos
Autores principales: Guffanti, Federica, Alvisi, Maria Francesca, Caiola, Elisa, Ricci, Francesca, De Maglie, Marcella, Soldati, Sabina, Ganzinelli, Monica, Decio, Alessandra, Giavazzi, Raffaella, Rulli, Eliana, Damia, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564949/
https://www.ncbi.nlm.nih.gov/pubmed/32847049
http://dx.doi.org/10.3390/cancers12092398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564949/
https://www.ncbi.nlm.nih.gov/pubmed/32847049
http://dx.doi.org/10.3390/cancers12092398

Ejemplares similares